Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
3
×
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
3
×
investing
startups
third rock ventures
allosteric
ally bridge group
antisense oligonucleotide
atlas venture
atopic dermatitis
autoimmune disorders
benzodiazepines
big data analytics
biogen
blackrock
blackstone group
blackstone life sciences
brace pharma
casdin capital
cleva pharma
columbia university
david goldstein
deals
depression
diabetic nephropathy
drug discovery
dupilumab
epi4k
epilepsy
essential tremor
eventide asset management
focal segmental glomerulosclerosis
glaxosmithkline
goldfinch bio
What
medicines
new
3
×
genetic
address
adds
ago
aims
allosteric
analysis
backed
bio
biotech
bring
cause
ceo
clinic
company
develop
disease
diseases
drug
drugs
elusive
employing
epilepsy
genes
goldfinch
hotspot
ipo
kidney
later
lead
links
marcio
million
molecules
mutations
neuro
path
potential
Language
unset
Current search:
new
×
biotech
×
boston
×
" clinical trials "
×
" national top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs